For World AIDS Day, Curtis Chan from the Kirby Institute talks through the findings of the PrEP Appeal Study. The research found that cost and access are the main barriers to more people using pre-exposure prophylaxis, or PrEP.
Three academics from UNSW Sydney have been recognised for their outstanding contributions to injury research, treatments for HIV, viral hepatitis and COVID-19, and leadership in immunology.
The Kirby Institute has developed the first non-English version of its AI-driven epidemic warning tool EPIWATCH, expanding its availability in one of the world's most populous countries.
The World Health Organization has classified the EG.5 family of Omicron variants, including Eris, as ‘variants of interest’. What does that mean? And how does Eris differ to other Omicron variants?
Project goals include improving long-term health for people living with HIV, fighting kidney disease and lessening the negative effects of chemotherapy in cancer patients.
